carbamates has been researched along with mycophenolic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, T; Suzuki, S | 1 |
| Jacobsohn, DA; Vogelsang, GB | 1 |
| Chen, P; Cheney, DL; Fleener, CA; Gu, HH; Guo, J; Hollenbaugh, DL; Iwanowicz, EJ; Murali Dhar, TG; Pitts, WJ; Rouleau, KA; Shen, Z; Townsend, RM; Watterson, SH | 1 |
| Baroudy, BM; Liu, R; Malcolm, BA; Reyes, GR; Zhou, S | 1 |
| Almquist, SJ; Ford, PJ; Germann, UA; Jain, J; Nimmesgern, E; Shlyakhter, D; Wang, Y | 1 |
| Huang, M; Itahana, K; Ji, Y; Mitchell, B; Zhang, Y | 1 |
| Pockros, PJ; Shields, WW | 1 |
| Bellissant, E; Ben Ali, Z; Boglione-Kerrien, C; Guyader, D; Jezequel, C; Lemaitre, F; Tron, C; Verdier, MC | 1 |
1 review(s) available for carbamates and mycophenolic acid
| Article | Year |
|---|---|
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbamates; Chronic Disease; Combined Modality Therapy; Cyclosporine; Daclizumab; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin-11; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; T-Lymphocytes; Tacrolimus | 2002 |
7 other study(ies) available for carbamates and mycophenolic acid
| Article | Year |
|---|---|
Carbamoyl mycophenolic acid ethylester, an oral antitumor agent.
Topics: Administration, Oral; Animals; Carbamates; Carcinoma, Ehrlich Tumor; Leukemia L1210; Mice; Mycophenolic Acid; Sarcoma 180 | 1976 |
Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety.
Topics: Animals; Carbamates; Cell Line; Cricetinae; Cricetulus; Enzyme Inhibitors; IMP Dehydrogenase; Inhibitory Concentration 50; Lymphocyte Activation; Mycophenolic Acid; Oxazoles; Phenylurea Compounds; Structure-Activity Relationship; T-Lymphocytes | 2003 |
The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.
Topics: Antimetabolites; Carbamates; Cell Line, Transformed; Enzyme Inhibitors; Genome, Viral; Guanosine; Hepacivirus; Humans; IMP Dehydrogenase; Mutation; Mycophenolic Acid; Phenylurea Compounds; Replicon; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA; RNA, Viral; Transfection; Virus Replication | 2003 |
Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Topics: Carbamates; Enzyme Inhibitors; Humans; IMP Dehydrogenase; Isoenzymes; Leukocytes, Mononuclear; Lymphocytes; Mycophenolic Acid; Phenylurea Compounds; RNA, Messenger; Tumor Cells, Cultured | 2004 |
Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption.
Topics: Animals; Carbamates; Cell Line, Tumor; Cell Nucleolus; Cell Proliferation; Cell Survival; Gene Expression Regulation; Genes, p53; Guanine Nucleotides; Humans; IMP Dehydrogenase; K562 Cells; Mice; Mycophenolic Acid; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA Precursors; RNA, Ribosomal | 2008 |
Ribavirin analogs.
Topics: Anemia, Hemolytic; Antiviral Agents; Carbamates; Hepacivirus; Hepatitis C; Humans; IMP Dehydrogenase; Mycophenolic Acid; Phenylurea Compounds; Ribavirin | 2009 |
Managing Drug-Drug Interaction Between Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Mycophenolate Mofetil.
Topics: 2-Naphthylamine; Aged; Anilides; Antibiotics, Antineoplastic; Antiviral Agents; Carbamates; Cyclopropanes; Cytochrome P-450 CYP3A Inhibitors; Disease Management; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Hepatitis C; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Mycophenolic Acid; Proline; Ritonavir; Sulfonamides; Uracil; Valine | 2017 |